Immunomonitoring Unit and Translational Research
This Immunomonitoring Unit (Head: E.M. Inderberg) is a heritage from the former research group of Prof. G. Gaudernack and was included in the Department of Cellular Therapy in 2012. We are located in the Oslo Cancer Cluster Incubator. The activities of the Unit are divided in two:
(1) The immunomonitoring lab provides analyses of immune responses of patients treated at the Department including vaccinated patients (DC, peptides, etc.). In addition to the hospital service, it provides immunomonitoring for private companies running clinical trials at our Hospital or collaborators.
(2) The research lab has the capacity to undertake complete pre-clinical studies for immunotherapeutic molecules such as vaccines and adoptive T cell transfer (Universal Killer). It possesses the competence to deliver molecular biology products isolated from patient material (Adoptive T-cell Therapy), to perform cellular assays and in vivo animal studies. Finally, innovative tools are also developed in collaboration with academy (CAR) and private companies.
We are located at the OCCI